Eckfeldt Craig E, Mendenhall Eric M, Flynn Catherine M, Wang Tzu-Fei, Pickart Michael A, Grindle Suzanne M, Ekker Stephen C, Verfaillie Catherine M
Division of Hematology, Oncology, and Transplantation, Department of Medicine, Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, USA.
PLoS Biol. 2005 Aug;3(8):e254. doi: 10.1371/journal.pbio.0030254. Epub 2005 Jul 5.
Although several reports have characterized the hematopoietic stem cell (HSC) transcriptome, the roles of HSC-specific genes in hematopoiesis remain elusive. To identify candidate regulators of HSC fate decisions, we compared the transcriptome of human umbilical cord blood and bone marrow (CD34+)(CD33-)(CD38-)Rho(lo)(c-kit+) cells, enriched for hematopoietic stem/progenitor cells with (CD34+)(CD33-)(CD38-)Rho(hi) cells, enriched in committed progenitors. We identified 277 differentially expressed transcripts conserved in these ontogenically distinct cell sources. We next performed a morpholino antisense oligonucleotide (MO)-based functional screen in zebrafish to determine the hematopoietic function of 61 genes that had no previously known function in HSC biology and for which a likely zebrafish ortholog could be identified. MO knock down of 14/61 (23%) of the differentially expressed transcripts resulted in hematopoietic defects in developing zebrafish embryos, as demonstrated by altered levels of circulating blood cells at 30 and 48 h postfertilization and subsequently confirmed by quantitative RT-PCR for erythroid-specific hbae1 and myeloid-specific lcp1 transcripts. Recapitulating the knockdown phenotype using a second MO of independent sequence, absence of the phenotype using a mismatched MO sequence, and rescue of the phenotype by cDNA-based overexpression of the targeted transcript for zebrafish spry4 confirmed the specificity of MO targeting in this system. Further characterization of the spry4-deficient zebrafish embryos demonstrated that hematopoietic defects were not due to more widespread defects in the mesodermal development, and therefore represented primary defects in HSC specification, proliferation, and/or differentiation. Overall, this high-throughput screen for the functional validation of differentially expressed genes using a zebrafish model of hematopoiesis represents a major step toward obtaining meaningful information from global gene profiling of HSCs.
尽管已有多篇报道对造血干细胞(HSC)转录组进行了特征描述,但HSC特异性基因在造血过程中的作用仍不明确。为了鉴定HSC命运决定的候选调节因子,我们比较了人脐带血和骨髓中富集造血干/祖细胞的(CD34+)(CD33-)(CD38-)Rho(lo)(c-kit+)细胞与富集定向祖细胞的(CD34+)(CD33-)(CD38-)Rho(hi)细胞的转录组。我们鉴定出在这些发育起源不同的细胞来源中保守的277个差异表达转录本。接下来,我们在斑马鱼中进行了基于吗啉代反义寡核苷酸(MO)的功能筛选,以确定61个在HSC生物学中以前未知功能且可能鉴定出斑马鱼直系同源物的基因的造血功能。MO敲低14/61(23%)的差异表达转录本导致发育中的斑马鱼胚胎出现造血缺陷,受精后30和48小时循环血细胞水平改变证明了这一点,随后通过定量RT-PCR检测红系特异性hbae1和髓系特异性lcp1转录本得到证实。使用独立序列的第二种MO重现敲低表型,使用错配MO序列则无此表型,以及通过基于cDNA的斑马鱼spry4靶向转录本过表达挽救表型,证实了该系统中MO靶向的特异性。对spry4缺陷斑马鱼胚胎的进一步表征表明,造血缺陷并非由于中胚层发育中更广泛的缺陷,因此代表了HSC特化、增殖和/或分化中的原发性缺陷。总体而言,这种使用斑马鱼造血模型对差异表达基因进行功能验证的高通量筛选,是朝着从HSC的全基因组分析中获取有意义信息迈出的重要一步。